This week, Urodynamix Technologies Ltd. reported exciting news: Financial results for its fiscal first quarter (ended March 31) showed a 1,269%increase from revenues in Q1 2008. The spike resulted from the first commercial sales of the company's URO NIRS 2000 in the quarter--and as of March 31, the company had an order backlog of $92,576.
This week, Urodynamix Technologies Ltd. reported exciting news: Financial results for its fiscal first quarter (ended March 31) showed a 1,269% increase from revenues in Q1 2008. The spike resulted from the first commercial sales of the company's URO NIRS 2000 in the quarter--and as of March 31, the company had an order backlog of $92,576.
Urodynamix has been busy working partnerships to get its near infrared spectroscopy products out into the world. For instance a new agreement with pharmaceuticals giant Pfizer has the partners collaborating on promotional programs to increase awareness of UroNIRS Bladder Monitor technology among urologists and medical professionals. And a product development and distribution agreement with Timm Medical Technologies aims to apply NIRS to erectile dysfunction.
Wednesday, June 3, 2009
Photonics' impact on ophthalmology
Optics and photonics technologies have advanced ophthalmology at least as much as any other medical specialty. Both the excimer laser and optical coherence tomography (OCT) figured prominently at the recent American Academy of Ophthalmology annual meeting. Since then, a research report urged greater access to laser and photodynamic treatments, saying such availability would reduce the incidence of future blindness.
Optics and photonics technologies have advanced ophthalmology at least as much as any other medical specialty. Both the excimer laser and optical coherence tomography (OCT) figured prominently at the recent American Academy of Ophthalmology annual meeting. Since then, a research report, urged greater access to laser and photodynamic treatments saying such availability would reduce the incidence of future blindness.
Last week's announcement of the 2009 PhAST/Laser Focus World Innovation Award winner, BioPhotonic Solutions' femtoFIT, has implications for corrective eye surgery, according to the award judges. And a new low-cost camera promises to expand the technologies' impact to eye care for millions of underserved people around the world.
In another inspiring look toward the future, the open publication of a massive data base of hi-res OCT images hopes to facilitate development of macular degeneration-diagnosis software.
Optics and photonics technologies have advanced ophthalmology at least as much as any other medical specialty. Both the excimer laser and optical coherence tomography (OCT) figured prominently at the recent American Academy of Ophthalmology annual meeting. Since then, a research report, urged greater access to laser and photodynamic treatments saying such availability would reduce the incidence of future blindness.
Last week's announcement of the 2009 PhAST/Laser Focus World Innovation Award winner, BioPhotonic Solutions' femtoFIT, has implications for corrective eye surgery, according to the award judges. And a new low-cost camera promises to expand the technologies' impact to eye care for millions of underserved people around the world.
In another inspiring look toward the future, the open publication of a massive data base of hi-res OCT images hopes to facilitate development of macular degeneration-diagnosis software.
Subscribe to:
Posts (Atom)